Scott D Grosse1, Norman J Waitzman2, Ninee Yang3, Karon Abe4, Wanda D Barfield5. 1. National Center on Birth Defects and Developmental Disabilities, sgrosse@cdc.gov. 2. Department of Economics, University of Utah, Salt Lake City, Utah. 3. National Center for Health Statistics, and. 4. National Center on Birth Defects and Developmental Disabilities. 5. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; and.
Abstract
BACKGROUND: Care for infants born preterm or with major birth defects is costly. Specific estimates of financial burden for different payers are lacking, in part because use of administrative data to identify preterm infants and costs is challenging. METHODS: We used private health insurance claims data and billing codes to identify live births during 2013 and calculated first-year expenditures for employer-sponsored health plans for infants born preterm, both overall and stratified by major birth defects. RESULTS: We conservatively estimated that 7.7% of insured infants born preterm accounted for 37% of $2.0 billion spent by participating plans on the care of infants born during 2013. With a mean difference in plan expenditures of ∼$47 100 per infant, preterm births cost the included plans an extra $600 million during the first year of life. Extrapolating to the national level, we projected aggregate employer-sponsored plan expenditures of $6 billion for infants born preterm during 2013. Infants with major birth defects accounted for 5.8% of preterm births but 24.5% of expenditures during infancy. By using an alternative algorithm to identify preterm infants, it was revealed that incremental expenditures were higher: $78 000 per preterm infant and $14 billion nationally. CONCLUSION: Preterm births (especially in conjunction with major birth defects) represent a substantial burden on payers, and efforts to mitigate this burden are needed. In addition, researchers need to conduct studies using linked vital records, birth defects surveillance, and administrative data to accurately and longitudinally assess per-infant costs attributable to preterm birth and the interaction of preterm birth with major birth defects.
BACKGROUND: Care for infants born preterm or with major birth defects is costly. Specific estimates of financial burden for different payers are lacking, in part because use of administrative data to identify preterm infants and costs is challenging. METHODS: We used private health insurance claims data and billing codes to identify live births during 2013 and calculated first-year expenditures for employer-sponsored health plans for infants born preterm, both overall and stratified by major birth defects. RESULTS: We conservatively estimated that 7.7% of insured infants born preterm accounted for 37% of $2.0 billion spent by participating plans on the care of infants born during 2013. With a mean difference in plan expenditures of ∼$47 100 per infant, preterm births cost the included plans an extra $600 million during the first year of life. Extrapolating to the national level, we projected aggregate employer-sponsored plan expenditures of $6 billion for infants born preterm during 2013. Infants with major birth defects accounted for 5.8% of preterm births but 24.5% of expenditures during infancy. By using an alternative algorithm to identify preterm infants, it was revealed that incremental expenditures were higher: $78 000 per preterm infant and $14 billion nationally. CONCLUSION: Preterm births (especially in conjunction with major birth defects) represent a substantial burden on payers, and efforts to mitigate this burden are needed. In addition, researchers need to conduct studies using linked vital records, birth defects surveillance, and administrative data to accurately and longitudinally assess per-infant costs attributable to preterm birth and the interaction of preterm birth with major birth defects.
Authors: Kimmie K McLaurin; Caroline B Hall; E Anne Jackson; Oksana V Owens; Parthiv J Mahadevia Journal: Pediatrics Date: 2009-02 Impact factor: 7.124
Authors: John P Barrett; Carter J Sevick; Ava Marie S Conlin; Gia R Gumbs; Sydney Lee; Diane P Martin; Tyler C Smith Journal: J Registry Manag Date: 2012
Authors: Qian Li; Susan E Andrade; William O Cooper; Robert L Davis; Sascha Dublin; Tarek A Hammad; Pamala A Pawloski; Simone P Pinheiro; Marsha A Raebel; Pamela E Scott; David H Smith; Inna Dashevsky; Katherine Haffenreffer; Karin E Johnson; Sengwee Toh Journal: Pharmacoepidemiol Drug Saf Date: 2013-01-21 Impact factor: 2.890
Authors: Margaret A Honein; Russell S Kirby; Robert E Meyer; Jian Xing; Nyasha I Skerrette; Nataliya Yuskiv; Lisa Marengo; Joann R Petrini; Michael J Davidoff; Cara T Mai; Charlotte M Druschel; Samara Viner-Brown; Lowell E Sever Journal: Matern Child Health J Date: 2008-05-17
Authors: Rebecca B Russell; Nancy S Green; Claudia A Steiner; Susan Meikle; Jennifer L Howse; Karalee Poschman; Todd Dias; Lisa Potetz; Michael J Davidoff; Karla Damus; Joann R Petrini Journal: Pediatrics Date: 2007-07 Impact factor: 7.124
Authors: Annelise C Arth; Sarah C Tinker; Regina M Simeone; Elizabeth C Ailes; Janet D Cragan; Scott D Grosse Journal: MMWR Morb Mortal Wkly Rep Date: 2017-01-20 Impact factor: 17.586
Authors: Kristin Bergman; Nina E Forestieri; Vito L Di Bona; Scott D Grosse; Cynthia A Moore Journal: Birth Defects Res Date: 2022-01-04 Impact factor: 2.661
Authors: Andrew L Beam; Inbar Fried; Nathan Palmer; Denis Agniel; Gabriel Brat; Kathe Fox; Isaac Kohane; Anna Sinaiko; John A F Zupancic; Joanne Armstrong Journal: J Perinatol Date: 2020-02-26 Impact factor: 2.521